Modifiable Risk Factors Tied to Young-Onset Dementia
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Dec. 28, 2023 -- Several modifiable factors are associated with a higher risk for young-onset dementia (YOD), according to a study published online Dec. 26 in JAMA Neurology.
Stevie Hendriks, Ph.D., from Maastricht University in the Netherlands, and colleagues examined 39 factors associated with the incidence of YOD from the literature using data from 356,052 participants younger than 65 years in the U.K. Biobank (baseline assessment 2006 to 2010 and follow-up until March 31, 2021).
The researchers found that during the study period, there were 485 incident YOD cases (51.8 percent men), yielding an incidence rate of 16.8 per 100,000 person-years. Fifteen of the 39 factors were significantly associated with a higher YOD risk, including lower formal education, lower socioeconomic status, carrying two apolipoprotein ε4 alleles, no alcohol use, alcohol use disorder, social isolation, vitamin D deficiency, high C-reactive protein levels, lower handgrip strength, hearing impairment, orthostatic hypotension, stroke, diabetes, heart disease, and depression.
"In this study, several factors, mostly modifiable, were associated with a higher risk of YOD," the authors write. "These modifiable risk factors should be incorporated in future dementia prevention initiatives and raise new therapeutic possibilities for YOD."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-29 22:15
Read more
- Study Characterizes Pediatric Patients Self-Presenting With Major Trauma
- Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
- Serena Williams Has Large Benign Cyst Removed From Neck
- American College of Gastroenterology, Oct. 25-30
- Better Prepared Emergency Departments Could Save Children's Lives
- New Combo Drug Therapy Halves Death Risk From Advanced Hodgkin Lymphoma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions